Corporate Website Design for Public & Pre-IPO Companies by VendorGroup®
Your Vision
Our Expertise
Memorable first impressions that resonate and build trust.
Bespoke Design
We craft corporate websites with tailored visuals and precision functionality, creating a design as unique as your company.
Reliable & Secure
Enjoy 99.99% uptime with advanced infrastructure and robust security, keeping your site accessible and protected 24/7.
Always-On Support
Get round-the-clock expert help and fully managed services for a seamless, worry-free experience.
Always Compliant
Stay aligned with industry standards through automated updates and proactive compliance monitoring.
Custom Automation
Streamline workflows with a CMS that combines powerful automation and full customization.
Accessible Everywhere
Deliver a seamless, mobile-friendly experience with inclusive designs that engage every visitor.
Recent Corporate Website Projects
Genvor
Paulex Bio
Paulex Bio is a biopharmaceutical company on a mission to eliminate the root cause of diabetes. Because for us, this is about more than science. It is about the families who wake up every day facing the relentless burden of this disease. That human reality fuels everything we do.
See the Live Site
Lahjavida
Lahjavida Bio is developing targeted cancer therapies that use proprietary Dye-Drug Conjugates (DDCs) to deliver chemotherapy directly to tumors, with the goal of improving efficacy while reducing side effects.
See the Live Site
Stablecoin Development Corporation
NYSE American: SDEV
SDEV is building a publicly traded platform focused on the stablecoin ecosystem, beginning with a strategic position in Sky and expanding into revenue-generating opportunities across digital financial infrastructure.
See the Live Site
EMulate Therapeutics
EMulate Therapeutics is developing wearable digital therapies that use proprietary electromagnetic signals to emulate drug activity and treat cancer, mental health disorders, and pain without pharmaceuticals. oncology, mental health, and pain management.
See the Live Site
CERo Therapeutics
Nasdaq: CERO
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.
See the Live Site
Bevilacqua PLLC
Bevilacqua PLLC is a transactional law firm based in Washington, D.C., specializing in corporate and securities law for both private and publicly held companies. Bevilacqua LLC Their services encompass going public, financing, mergers and acquisitions, and equity crowdfunding, with a notable emphasis on assisting entrepreneurs and company leaders in achieving their business objectives.
See the Live Site
Genvor
OTCQB: GNVR
Genvor is a biotech company developing AI-designed peptide solutions for agriculture. Their products include eco-friendly fungicides, seed traits, and bio-stimulant peptides that boost crop yield, resilience, and food safety without harmful residues. Founded in 2017, Genvor operates with a licensing-first, capital-light model, partnering with leaders like the USDA and Bayer (Golden Ticket awardee in 2024). Headquarters are in Chapel Hill, NC, with corporate filings in Nevada.
See the Live SiteContact
VendorGroup®
